Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis.
Pereira RL, Reis VO, Semedo P, Buscariollo BN, Donizetti-Oliveira C, Cenedeze MA, Soares MF, Pacheco-Silva A, Savage PB, Câmara NO, et al. PLoS One. 2012; 7(3):e32454. Epub 2012 Mar 12.